Natesan Murugesan - Concepedia

Author

Natesan Murugesan

Bristol-Myers Squibb (United States)

Also Known As

Natesan Murugesan

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Pennsylvania State University University of Virginia Bristol-Myers Squibb (Germany)Bristol-Myers Squibb (Sweden)

About

Natesan Murugesan is an author at Bristol-Myers Squibb (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	898
2	Biochemistry	13	14	724
3	Natural Sciences	12	13	659
4	Engineering	3	3	165
5	Biomolecular Engineering	3	3	225

Natesan Murugesan

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
The Discovery of Sulfonamide Endothelin Antagonists and the Development of the Orally Active ETA Antagonist 5-(Dimethylamino)-N-(3,4-dimethyl-5- isoxazolyl)-1-naphthalenesulfonamide Philip D. Stein, John T. Hunt, David Floyd, Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapy3,4-Dimethyl-5- IsoxazolylChemical Biology	1994	137
Bleomycin as an oxene transferase. Catalytic oxygen transfer to olefins Natesan Murugesan, Sidney M. Hecht Journal of the American Chemical Society EngineeringChemical AnalysisSecondary MetaboliteOrganic ChemistryAltmetrics	1985	89
Dual Angiotensin II and Endothelin A Receptor Antagonists: Synthesis of 2‘-Substituted N-3-Isoxazolyl Biphenylsulfonamides with Improved Potency and Pharmacokinetics Natesan Murugesan, Zhengxiang Gu, Leena Fadnis, Journal of Medicinal Chemistry Cardiovascular PharmacologyReceptor AntagonistPharmacotherapyMolecular PharmacologyMedicinal Chemistry	2004	86
Chemistry of the alkali-labile lesion formed from iron(II) bleomycin and d(CGCTTTAAAGCG) Hiroshi Sugiyama, Cheng Xu, Natesan Murugesan, Biochemistry	1988	83
Analysis of products formed during bleomycin-mediated DNA degradation Natesan Murugesan, Cheng Xu, Guy M. Ehrenfeld, Biochemistry	1985	72
Structure of the alkali-labile product formed during iron(II)-bleomycin-mediated DNA strand scission Hiroshi Sugiyama, Cheng Xu, Natesan Murugesan, Journal of the American Chemical Society Bioorganic ChemistryAltmetric Attention ScoreMolecular BiologyChemical BiologyRedox Biology	1985	70
The chemistry of vicinal tricarbonyls. A stable vinyl tricarbonyl hydrate as a di- and trielectrophile Harry H. Wasserman, James M. Fukuyama, Natesan Murugesan, Journal of the American Chemical Society Inorganic ChemistryChemical EngineeringChemical MeasurementEngineeringChemical Analysis	1989	64
Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of <i>N</i>-[[2‘-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1‘-biphenyl]- 2-yl]methyl]-<i>N</i>,3,3-trimethylbutanamide (BMS-207940), A Highly Potent and Orally Active ET<sub>A</sub> Selective Antagonist Natesan Murugesan, Zhengxiang Gu, Steven H. Spergel, Journal of Medicinal Chemistry Receptor Antagonist N-Molecular PharmacologyMedicinal ChemistryPharmacological StudyBiochemistry	2002	62
Activation of oxygen and mediation of DNA degradation by manganese-bleomycin Guy M. Ehrenfeld, Natesan Murugesan, Sidney M. Hecht Inorganic Chemistry Altmetric Attention ScoreMolecular BiologyChemical BiologyRedox BiologyOxidative Stress	1984	62
Discovery of <i>N</i>-Isoxazolyl Biphenylsulfonamides as Potent Dual Angiotensin II and Endothelin A Receptor Antagonists Natesan Murugesan, John E. Tellew, Zhengxiang Gu, Journal of Medicinal Chemistry	2002	53

Page 1